Table 1.
Clinical baseline characteristics, stratified by sex.
| All Patients n = 270 |
Women n = 109 (40.4%) |
Men n = 161 (59.6%) |
p-Value | |
|---|---|---|---|---|
| Age (years) | 60 ± 21 | 64 ± 20 | 57.3 ± 21.0 | 0.01 * |
| BMI (kg/m2) | 26.3 ± 4.6 | 26.5 ± 5.4 | 26.2 ± 4.1 | 0.84 |
| BSA (m2) | 1.90 ± 1.26 | 1.77 ± 0.21 | 1.99 ± 0.19 | <0.001 * |
| Hypertension (%) | 65.4 | 68.0 | 63.3 | 0.46 |
| Atrial fibrillation (%) | 28.1 | 27.5 | 28.6 | 0.85 |
| Diabetes (%) | 13.6 | 18.6 | 9.5 | 0.046 * |
| Hyperlipidemia (%) | 39.5 | 31.7 | 45.7 | 0.03 * |
| CAD (%) | 27.5 | 23.5 | 30.7 | 0.23 |
| Previous PCI (%) | 10.0 | 4.9 | 14.2 | 0.02 * |
| Previous CABG (%) | 7.9 | 7.8 | 7.9 | 0.99 |
| Previous MI (%) | 9.6 | 5.9 | 12.6 | 0.09 |
| Previous stroke (%) | 3.9 | 4.3 | 3.5 | 0.75 |
| Hematocrit (g/dL) | 39.4 ± 5.1 | 37.1 ± 3.9 | 41.0 ± 5.2 | <0.001 * |
| eGFR (mL/min/1.73 m2) | 66.1 ± 25.9 | 64.1 ± 26.8 | 67.5 ± 25.3 | 0.20 |
| Bicuspid valve (%) | 20.5 | 7.0 | 29.0 | <0.001 * |
Numbers indicate % or median and corresponding interquartile range. * indicates statistical significance, defined as a p-value < 0.05. BMI indicates body mass index; BSA, body surface area; CAD, coronary artery disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; MI, myocardial infarction; eGFR, estimated glomerular filtration rate.